Augie’s Quest to Cure ALS Completes $5.8 Million Commitment to Fund ALS TDI’s Translational Research Center
The ALS Therapy Development Institute (ALS TDI) is proud to announce that Augie’s Quest to Cure ALS has fulfilled its $5.8 million commitment, pledged in 2021, to advance ALS research. This transformative funding has directly supported the Augie’s Quest Translational Research Center... - December 13, 2024
Superior Rail & Iron Works Named First-Ever Diamond Sponsor for ALS TDI’s White Coat Affair Gala
The ALS Therapy Development Institute (ALS TDI) has announced that Superior Rail & Iron Works, Inc. will be the first-ever Diamond Sponsor for the annual White Coat Affair gala, taking place on October 5, 2024, at the Boston Sheraton. Superior Rail & Iron Works, Inc., which was the gala’s Title Sponsor last year, is continuing its support, helping ALS TDI push forward with critical research to find treatments for ALS. - September 19, 2024
ALS Therapy Development Institute Commemorates 25th Anniversary at the Leadership Weekend in October
Taking place from October 3-5, 2024, in the Boston area, ALS TDI’s Leadership Weekend features a series of community-focused events, including an Open House at ALS TDI’s cutting-edge research lab, the ALS TDI Research Summit, and the White Coat Affair gala. - September 03, 2024
Limited Opportunity: Enroll in Ales for ALS 2024 Today, Secure Your Spot as Part of a Growing National Movement
Ales for ALS invites brewers to craft distinctive and flavorful beers using a custom hop blend generously donated by Yakima Chief Hops. In exchange, participating brewers pledge to donate $1 for every pint sold, directly contributing to groundbreaking ALS research at the ALS Therapy Development Institute (ALS TDI). - May 04, 2024
ALS TDI Launches ALS Trial Navigator: A Revolutionary Platform to Simplify Access to Clinical Trials
The ALS Therapy Development Insitute (ALS TDI) has announced the beta launch of the ALS Trial Navigator. This innovative set of tools is designed to guide people with ALS and caregivers through the process of finding and understanding ALS clinical trials – with the ultimate goal of personalizing the search process and helping users make informed decisions about participation in trials. - February 29, 2024
Announcing the Ales for ALS™ Roadtrip Across America
Over the coming months, Ales for ALS™ will be traveling across the country in an RV to connect with brewers and beer drinkers – all in support of ALS research. - December 04, 2023
The ALS Therapy Development Institute and Unite Genomics Partner to Integrate Electronic Health Records Into the ALS Research Collaborative
The ALS Therapy Development Institute (ALS TDI) is partnering with Unite Genomics, a leading healthcare data analytics company, to integrate electronic health record (EHR) data into the ALS Research Collaborative (ARC) via Unite Genomics’ state-of-the-art healthcare data access and analytics... - August 02, 2023
Cyclists Ride Through MA, NH, and ME in Tri-State Trek to Benefit ALS Research
June 24-25, cyclists of all levels are invited to participate in the Tri-State Trek, a New England cycling event raising funds for cutting-edge research to end ALS. - May 03, 2023
Fight ALS Film Fest Aims to Continue the Momentum to Beat ALS
The second annual Festival will explore universal themes of life-changing diseases through examination of ALS. - April 26, 2023
Breaking Barriers: ALS TDI Unveils Groundbreaking ALS Research Collaborative (ARC) to Accelerate Global Research in ALS
The ALS Research Collaborative will revolutionize ALS research by providing scientists with unprecedented access to the data and tools they need to discover new treatments and accelerate progress toward cures for ALS. - March 15, 2023
ALS Therapy Development Institute Announces Superior Rail & Iron Works, Inc. as First Title Sponsor of White Coat Affair Gala
Superior Rail & Iron Works, Inc. will be the first Title Sponsor of the White Coat Affair gala, being held on October 15, 2022, at the Boston Sheraton to raise funds for ALS research. - September 28, 2022
Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI
Eledon Pharmaceuticals announced topline results from their Phase 2 trial of tegoprubart (formerly AT1501), a drug invented and developed at the ALS Therapy Development Institute (ALS TDI). The Phase 2a trial in ALS was a 12-week, open label, dose escalating, safety, and biomarker study. The... - May 31, 2022
ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit
The ALS TDI scientists will be showcasing significant advancements in ALS research through multiple poster presentations. These posters will cover pre-clinical research exploring potential new therapeutic drug-like molecules and targets for ALS, as well as translational research analyzing patient data to identify new ALS biomarkers, drug targets, and patient populations. - May 25, 2022
The ALS TDI Discovery Biology Suite Dedicated in Honor of Liz Bodine to Speed Drug Development in ALS
The ALS Therapy Development Institute (ALS TDI) and Augie’s Quest to Cure ALS are proud to honor the commitment of Liz Bodine to facilitate more effective ALS drug discovery at ALS TDI, the world’s most comprehensive drug discovery lab dedicated solely to ALS. - May 04, 2022
Cyclists Support ALS Research with 3-Day, 270-Mile Ride from Boston to Greenwich in Tri-State Trek
Hundreds of riders to join the ride to end ALS this June and raise funds for cutting-edge ALS research. ALS TDI has received a $100,000 match for all donations made to the Tri-State Trek through the month of May. - May 03, 2022
“Fight ALS Film Fest” Aims to Shine a Spotlight on the World of ALS
Films explore universal themes of life-changing diseases through examination of ALS. Films and dialogue aim to improve understanding, uplift those affected, and expand the community. - April 25, 2022
ALS TDI Launches New Young Faces of ALS Program
The ALS Therapy Development Institute's Young Faces of ALS program spreads awareness about the impact that ALS can have on young people; launch coincides with MLB's inaugural Lou Gehrig Day. - June 02, 2021
Study Points to a New Unexplored Therapeutic Target for C9ORF72-mediated ALS
A novel discovery from scientists at the ALS Therapy Development Institute (ALS TDI) is the first to indicate that asymmetric di-methylation of arginine could be a promising target for ALS therapies. - September 09, 2020
On June 25, "How I Brewed This: Craft Brewer Series” to Feature Two Big Names in the Washington State Brewing Scene
The ALS Therapy Development Institute (ALS TDI) is excited to announce that on Thursday, June 25, they will be hosting the second episode of their new “How I Brewed This: Craft Brewer Series,” featuring Kevin Smith of Bale Breaker Brewing Company and Mike Smith of B.T. Loftus... - June 20, 2020
ALS TDI Hosts “Gamers vs. ALS” Virtual Livestream Event to Benefit Critical ALS Research
Gamers can join the livestream video game event on Tiltify, May 3-9, to raise funds for cutting-edge ALS research at the ALS Therapy Development Institute. - May 03, 2020
My-State Trek Virtual Event Provides New Opportunity to Support ALS Research While Social Distancing
Virtual event provides opportunities to get active at home and raise funds for cutting-edge ALS research at the ALS Therapy Development Institute (ALS TDI). - April 29, 2020
ALS Therapy Development Institute Announces Naming of Augie’s Quest Translational Research Center
“It’s really incredible. For 15 years, Augie’s Quest has been dedicated to raising the critical funds and broad awareness needed to help fast-track ALS TDI’s cutting-edge ALS research – specifically providing ALS TDI with more than $150 million to advance its efforts to end ALS,” commented Steven Perrin Ph.D., CEO of ALS TDI. - January 24, 2020
ALS TDI Collaboration with Google’s Project Euphonia Highlighted in Documentary Series Featuring Former NFL Player Tim Shaw “The Age of A.I.” Hosted by Robert Downey Jr.
The ALS Therapy Development Institute (ALS TDI), the world’s foremost drug discovery lab focused solely on finding treatments and cures for ALS, today proudly announced that it is featured in episode two of “The Age of A.I.,” a new YouTube Originals documentary series that takes... - December 18, 2019
ALS Therapy Development Institute Reflects on the Impact of Pete Frates and the Ice Bucket Challenge
On Monday it was announced that Pete Frates passed away due to complications from ALS. Pete was a leader in the ALS community and the inspiration for the Ice Bucket Challenge, which helped raise millions of dollars for ALS research and awareness. Though it has been five years since the Challenge,... - December 11, 2019
AT-1501, a Drug Discovered at the ALS Therapy Development Institute, Completes Phase I Trials
The ALS Therapy Development Institute (ALS TDI), a non-profit biotechnology company dedicated to the discovery and development of effective treatments for ALS, is pleased to share that AT-1501, a drug discovered and developed in the ALS TDI lab, has successfully completed Phase I clinical trials. - November 20, 2019
Cambridge Cider Social Invites You to Celebrate Autumn by Tasting Hard Ciders and Donuts at a Fun Outdoor Festival
On October 24, 2019 join the ALS Therapy Development Institute in Cambridge for an outdoor celebration of autumn with hard cider, apple cider donuts, seasonal snacks, music, and fun – all in support of a great cause. - September 10, 2019
Brewing a Cure 4 ALS Fundraiser Invites You to Enjoy Regional Beers and Wines While Fundraising for ALS Research
On Saturday, August 10, 2019, the first-ever Brewing a Cure 4 ALS fundraiser will be held at Technology Square in Cambridge, MA. Brewing a Cure 4 ALS invites community members to enjoy craft beer, wine, music, and food with the goal of raising money for ALS research at the ALS Therapy Development... - July 31, 2019
On August 18, Wear Your Nerdiest Costume and Run for a Great Cause at the Race 4 Research 5K in Cambridge
On Sunday, August 18, the ALS Therapy Development Institute (ALS TDI) will host the annual Race 4 Research 5K and Walk in Technology Square, Cambridge. The event will feature a chip-timed nerdy 5K road race (costumes encouraged), a 4-mile ALS awareness walk and wheelchair ride along the Charles,... - July 26, 2019
Orangetheory Fitness and Augie’s Quest Collaboration Funds Innovative Research at the ALS Therapy Development
This past May over 1,100 members of Orangetheory Fitness ran, rowed, and lifted, earning “splat points,” which they turned into $4.5 million in donations for Augie’s Quest to Cure ALS. With this donation Augie’s Quest is supporting non-profit biotech, the ALS Therapy Development Institute (ALS TDI), to fast track cure-driven drugs for ALS. - June 20, 2019
First Responders Unite to Arrest and Extinguish ALS
Inaugural Arrest and Extinguish event at Tanglewood raises over $50,000 for ALS research. - May 23, 2019
First Responders Unite to End ALS at Inaugural Arrest & Extinguish Event
On May 18th, first responders will unite for a tug-of-war event at Tanglewood to raise money for ALS research. - May 11, 2019
May is ALS Awareness Month - #AskMeAboutALS
May is ALS Awareness Month. The ALS Therapy Development Institute is inviting the general public to participate, and hoping to inspire a larger dialogue around ALS, through #AskMeAboutALS. - May 01, 2019
ALS Therapy Development Institute Announces Eighth Annual "The Cure Is Coming" 5k and Awareness Walk
Participants walk, ride or race to raise money and awareness to end ALS (Lou Gehrig's disease) - March 21, 2012
New, Interactive Social Media Fundraising Campaign, Arrest ALS, Launched
Innovative fundraising concept leverages social media to raise money and awareness to end ALS. - January 22, 2012